Research ReportsSharda Cropchem — Growth Momentum To Sustain Says Anand Rathi; Maintaining A 'Buy'
ADVERTISEMENT
Sharda Cropchem — Growth Momentum To Sustain Says Anand Rathi; Maintaining A 'Buy'
The recent correction in the stock price provides an attractive entry point for investors says Anand Rathi maintaining a Buy rating, with an unchanged target price of Rs 730,
The brokerage believes risk-reward is favorable for Sharda Cropchem stock.
(Photo for representative purposes only/ Source: iStock)
Sharda Cropchem's management expects the growth momentum to sustain, supported by the extensive registration pipeline, capex of Rs 4 billion-4.5 billion driving revenue growth and margins being aided by the company’s focus on operational efficiency.